| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 1,008,000 | 1,421,000 | 1,379,000 | 1,332,000 | | Cost of Revenue | 824,000 | 1,094,000 | 1,069,000 | 1,045,000 | | | Gross Profit | 184,000 | 327,000 | 310,000 | 287,000 | | | Operating Expenses | | Research Development | 35,000 | 37,000 | 35,000 | 41,000 | | Selling General and Administrative | 159,000 | 195,000 | 175,000 | 184,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (10,000) | 95,000 | 100,000 | 62,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (28,000) | 5,000 | 5,000 | | Earnings Before Interest And Taxes | (10,000) | 67,000 | 105,000 | 67,000 | | Interest Expense | 5,000 | 5,000 | 6,000 | 5,000 | | Income Before Tax | (15,000) | 62,000 | 99,000 | 62,000 | | Income Tax Expense | (1,000) | 7,000 | 17,000 | 17,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,000) | 55,000 | 82,000 | 45,000 | | | Non-recurring Events | | Discontinued Operations |
-
| 1,000 | (2,000) | (1,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (14,000) | 56,000 | 80,000 | 44,000 | | Preferred Stock And Other Adjustments | (1,000) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,000) | $56,000 | $80,000 | $44,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
